| A Multiple Dose Study of Debio 1450 [Intravenous (IV) and Oral] in Healthy Volunteers (NCT02214433) | Debiopharm International SA | 2014-08-01 |
| Study to Determine the Equivalence of Three Products Containing Metronidazole Benzoate. (NCT02146209) | Verisfield UK Ltd. Greek Branch | 2014-06-01 |
| A Single Dose Study of Debio 1450 in Healthy Subjects (NCT02162199) | Debiopharm International SA | 2014-06-01 |
| To Evaluate the Effectiveness(Immunogeneicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Adults (NCT02361866) | Green Cross Corporation | 2014-05-01 |
| A Phase I Study to Assess Safety, Tolerability and Pharmacokinetics of OP0595 (NCT02134834) | Meiji Seika Pharma Co., Ltd. | 2014-05-01 |
| Efficacy and Safety of Intravenous to Oral 6-Day Tedizolid Phosphate vs. Intravenous to Oral 10-Day Linezolid in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI) (NCT02066402) | Bayer | 2014-03-04 |
| Pharmacokinetics and Safety of Solithromycin Capsules in Adolescents (NCT01966055) | Melinta Therapeutics, Inc. | 2013-12-01 |
| TD-1607 MAD Study in Healthy Subjects (NCT01949103) | Theravance Biopharma | 2013-10-01 |
| Safety, Tolerability, Pharmacokinetics of Intravenous RPX2014 and RPX7009 in Healthy Adult Subjects (NCT01897779) | Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) | 2013-07-01 |
| A Single Dose Study To Investigate The Pharmacokinetics and Safety Of Dalbavancin In Hospitalized Children Aged 3 Months to 11 Years. (NCT01946568) | Durata Therapeutics Inc., an affiliate of Allergan plc | 2013-06-01 |
| Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile (NCT01744730) | Phillip Brian Smith | 2013-06-01 |
| Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010) (NCT01839188) | MCM Vaccines B.V. | 2013-05-01 |
| Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination (NCT01839175) | Sanofi Pasteur, a Sanofi Company | 2013-04-01 |
| Safety Study of Intravenous Biapenem (RPX2003) and RPX7009 Given Alone and in Combination (NCT01772836) | Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) | 2013-03-01 |
| Impact of Ceftriaxone and/or Fluoroquinolone (FQ) Treatment on the Gut Microbiota of Hospitalized Patients. (NCT02031588) | Assistance Publique - Hôpitaux de Paris | 2012-12-01 |
| Safety, Tolerability, Pharmacokinetics of Intravenous RPX7009 in Healthy Adult Subjects (NCT01751269) | Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) | 2012-12-01 |
| Safety & Efficacy of an Antibacterial Protein Molecule Applied Topically to the Nostrils of Volunteers and Patients (NCT01746654) | GangaGen, Inc. | 2012-12-01 |
| Early Procalcitonin Kinetics During Empirical Antibiotic Therapy in Critically Ill Patients (NCT02294695) | Domonkos Trásy | 2012-10-01 |
| Study of Complication Rates Associated With PICC for Left vs Right (NCT01638702) | Richard Lindsay | 2012-10-01 |
| Prospective Study to Optimize Vancomycin Dosing in Children and Adults Using Computer Software (NCT01932034) | Children's Hospital Los Angeles | 2012-09-01 |
| Children's Antibiotic Resistant Infections in Low Income Countries (NCT02074865) | Institut Pasteur | 2012-09-01 |
| Safety, Tolerability, Pharmacokinetics of Intravenous RPX2003 (Biapenem) in Healthy Adult Subjects (NCT01702649) | Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company) | 2012-08-01 |
| Study of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese Subjects (NCT01608815) | Sanofi Pasteur, a Sanofi Company | 2012-05-01 |
| Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011) (NCT01553279) | MCM Vaccines B.V. | 2012-03-30 |
| Effect of Xylitol on Oral Microbiota in Children (NCT01528969) | Kuwait University | 2012-03-01 |
| Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008) (NCT01480258) | MCM Vaccines B.V. | 2011-11-23 |
| Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative Pregnant Women and Their Offsprings (NCT01412801) | Novartis Vaccines | 2011-09-01 |
| To Evaluate the Effectiveness(Immunogenicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Children (NCT01402713) | Green Cross Corporation | 2011-08-01 |
| Effects of MRSA Bactericidal Gel To Promote Healing and Eliminate MRSA in cSSTI Vancogel(TM) (NCT00945152) | Robert S Berman MD | 2011-07-15 |
| Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007) (NCT01341639) | MCM Vaccines B.V. | 2011-05-26 |
| A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006) (NCT01340937) | Merck Sharp & Dohme LLC | 2011-05-10 |
| Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005) (NCT01337167) | Merck Sharp & Dohme LLC | 2011-04-19 |
| Bacterial Colonization in COPD in View of CAT Under ICS+LABA Therapy (NCT01819298) | Far Eastern Memorial Hospital | 2011-03-01 |
| The Rate of C-reactive Protein (CRP) Increase as a Marker for Bacterial Infections in Children (NCT01159470) | Shaare Zedek Medical Center | 2010-09-01 |
| Study Comparing the Safety and Efficacy of Two Doses of BC-3781 vs Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection (ABSSSI) (NCT01119105) | Nabriva Therapeutics AG | 2010-05-01 |
| Hospital Wide Roll-Out of Antimicrobial Stewardship (NCT01587937) | Sunnybrook Health Sciences Centre | 2010-04-01 |
| Changes in Microbiota and Iron Status After Iron Fortification of Complementary Foods (NCT01111864) | Swiss Federal Institute of Technology | 2010-02-01 |
| An Evaluation Of Three Dose Levels Of 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) In Healthy Adults (NCT01018641) | Pfizer | 2010-01-01 |
| A Study of Doripenem in Infants Less Than 12 Weeks of Age (NCT01381848) | Janssen Research & Development, LLC | 2009-10-01 |
| Zithromax-SR 2g, Special Investigation (Regulatory Post Marketing Commitment Plan) (NCT00998309) | Pfizer | 2009-10-01 |
| Ascending Dose Pharmacokinetic (PK) and Absolute Bioavailability (BA) (NCT00983255) | Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2009-09-01 |
| A Safety and Efficacy Study of Doripenem in Participants With Nosocomial Pneumonia, Complicated Intra-Abdominal Infections and Urinary Tract Infections (NCT00965848) | Janssen-Cilag Ltd.,Thailand | 2009-06-01 |
| Relative Bioavailability Study Of Two Lincomycin Hydrochloride Hard Gelatinous Capsule (NCT01058824) | Pfizer | 2009-04-01 |
| Regenerative Surgical Treatment of Peri-implantitis (NCT02500654) | Catrine Isehed | 2008-12-01 |
| A Study To Assess The Effect Of Linezolid On QTc Interval (NCT00795145) | Pfizer | 2008-12-01 |
| Validation Study of Combined Positron Emission Tomography/Computer Tomography to Diagnose Infection and Inflammation (NCT00835783) | Odense University Hospital | 2008-11-01 |
| French Study In ICU Patients Treated With Tigecycline (NCT00799591) | Wyeth is now a wholly owned subsidiary of Pfizer | 2008-09-01 |
| Study Of Dalbavancin Drug Levels Achieved In Hospitalized Adolescents Who Are Receiving Antibiotic Therapy For Bacterial Infections (NCT00678106) | Pfizer | 2008-09-01 |
| Procalcitonin Level and Kinetics in Children With Bacterial Infections (NCT00714402) | Shaare Zedek Medical Center | 2008-08-01 |
| What is the Prevalence of Methicillin-Resistant Staphylococcus Aureus in Skin and Soft Tissue Infections Presenting to the Emergency Departments of a Canadian Academic Health Care Center? (NCT00736554) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2008-07-01 |
| Study of AzaSite Versus Vigamox in the Tears of Healthy Volunteers (NCT00575367) | Merck Sharp & Dohme LLC | 2008-03-01 |
| Bacteriophage Therapy of Difficult-to-treat Infections (NCT05498363) | Queen Astrid Military Hospital | 2008-01-01 |
| Study of AzaSite Versus Vigamox Concentrations in the Conjunctiva and Aqueous Humor in Subjects Undergoing Routine Cataract Surgery (NCT00575380) | Merck Sharp & Dohme LLC | 2007-12-01 |
| Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years of Age (NCT00488345) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-12-01 |
| Study of AzaSite (Azithromycin) Versus Vigamox in the Conjunctiva of Healthy Volunteers (NCT00564447) | Merck Sharp & Dohme LLC | 2007-12-01 |
| A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia (NCT00515034) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2007-10-01 |
| PROcalcitonin Reduce Antibiotic Treatments in Acute-Ill Patients (PRORATA) (NCT00472667) | Assistance Publique - Hôpitaux de Paris | 2007-07-01 |
| Trial of Rapid Diagnostic Tests in Rural Ghana (NCT00493922) | London School of Hygiene and Tropical Medicine | 2007-07-01 |
| A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity (NCT00353158) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2007-05-25 |
| Study Evaluation Tazocin Intervention (NCT00488189) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-05-01 |
| Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections (NCT00423657) | Forest Laboratories | 2007-03-01 |
| Quinolone Resistance in Bloodstream Isolates of Escherichia Coli (NCT00449735) | University of Pittsburgh | 2007-03-01 |
| Clinical and Economic Impact of Interventions by a Clinical Pharmacist on Antibiotic Use on Surgical Wards (NCT00431483) | Ludwig-Maximilians - University of Munich | 2007-02-01 |
| Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections (NCT00424190) | Forest Laboratories | 2007-02-01 |
| Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections (DFI) With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis. (NCT00366249) | Wyeth is now a wholly owned subsidiary of Pfizer | 2007-01-01 |
| Human Innate Immune Responses To Mycobacterial Aerodigestive Tract Infection (NCT01074775) | St George's, University of London | 2006-09-01 |
| Tazocin Intervention Study (NCT00478855) | Wyeth is now a wholly owned subsidiary of Pfizer | 2006-09-01 |
| Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients (NCT00410527) | National Institutes of Health Clinical Center (CC) | 2006-08-11 |
| Evaluation of Atuna Racemosa Toxicity (NCT00318344) | Mayo Clinic | 2006-04-01 |
| Safety and Efficacy Study of Angiotech Central Venous Catheter to Prevent Bacterial Catheter Colonization (NCT00288418) | Angiotech Pharmaceuticals | 2005-12-01 |
| Experimental Phage Therapy of Bacterial Infections (NCT00945087) | Institute of Immunology and Experimental Therapy of the Polish Academy of Sciences | 2005-12-01 |
| Sub-Tenon's Injection of Triamcinolone and Ciprofloxacin in a Controlled-Release System for Cataract Surgery (NCT00431028) | Federal University of São Paulo | 2005-09-01 |
| Contrast-Enhanced US of Spleen, Liver and Kidney (NCT00190281) | Assistance Publique - Hôpitaux de Paris | 2005-08-01 |
| Unfractioned Heparin for Treatment of Sepsis (NCT00100308) | Universidad de Antioquia | 2005-07-01 |
| Therapeutic Zinc in Infant Bacterial Illness (NCT00347386) | Centre For International Health | 2005-07-01 |
| Study Evaluating the Association of Antibiotic Measures and Control of Bacterial Resistance (NCT01788449) | Wyeth is now a wholly owned subsidiary of Pfizer | 2005-05-01 |
| Study of the Safety and Effectiveness of Rabeprazole in Treatment of Helicobacter Pylori Infection in Adults. (NCT00216450) | Janssen Cilag Pharmaceutica S.A.C.I., Greece | 2004-10-01 |
| BAYQ3939, 1000 mg Tablet in Transrectal Needle Biopsies of the Prostate (TRNBP) - Infection Prophylaxis (NCT00670215) | Bayer | 2004-04-01 |
| Study Evaluating Emergency-use Tigecycline in Subjects With Resistant Pathogens. (NCT00205816) | Wyeth is now a wholly owned subsidiary of Pfizer | 2004-01-01 |
| Ciprofloxacin on Burned Patients (NCT00668044) | Bayer | 2002-11-01 |
| Study Evaluating Zosyn in Hospitalized Patients With Intra-abdominal Infection (NCT00044928) | Wyeth is now a wholly owned subsidiary of Pfizer | 2002-07-01 |
| Prevention of Catheter-Associated Infection With the Skin Disinfectant Octenidine Dihydrochloride (NCT00515151) | University Hospital Freiburg | 2002-05-01 |
| Antibiotic Treatment for Infections of Short Term In-dwelling Vascular Catheters Due to Gram Positive Bacteria (NCT00037050) | Pfizer | 2002-04-01 |
| New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus) (NCT00035854) | Pfizer | 2002-02-01 |
| Phase II Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Mucoid Exopolysaccharide Pseudomonas Aeruginosa Immune Globulin for Cystic Fibrosis (NCT00004747) | National Center for Research Resources (NCRR) | 1995-07-01 |
| A Study of the Safety and Effectiveness of Levofloxacin Compared With Lomefloxacin in the Treatment of Complicated Urinary Tract Infections (NCT00258102) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1993-01-01 |
| Expanded Access to Cefiderocol for the Intravenous Treatment of Severe Gram Negative Bacterial Infections (NCT03780140) | Shionogi | |
| A Study of Azithromycin in HIV-Infected Patients (NCT00002344) | Pfizer | |
| A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children (NCT00000811) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Phase I Study of the Clinical Pharmacology of Azithromycin in Buffy Coat of HIV-Infected Subjects. (NCT00002139) | Pfizer | |